• Dasatinib Monohydrate: Applied Workflows in CML and Ph+ ALL

  2026-07-17

  Dasatinib Monohydrate (BMS-354825) unlocks advanced research workflows for chronic myeloid leukemia and imatinib-resistant models by combining potent kinase inhibition with exceptional protocol flexibility. Discover evidence-backed setup parameters, troubleshooting strategies, and how recent findings on neutrophil extracellular traps (NETs) can refine translational research.

• Humanized Mice Enable Accurate PK Profiling of Ester Prodrug

  2026-07-17

  The referenced study establishes that humanized liver mice are essential for accurately modeling the metabolism and pharmacokinetics of the carboxylic ester prodrug HD56, designed for neurodegenerative therapy. The findings highlight significant species differences and provide a method for improved translation of in vitro results to human-relevant in vivo outcomes.

• Structure–Activity of Novel 3-DT Brassinosteroid Derivatives

  2026-07-16

  This study introduces a new class of 3-dehydroteasterone (3-DT) derivatives featuring 23,24-dinorcholanic side chains and benzoate groups at C-22, elucidating how specific structural modifications influence plant growth-regulating activity. By benchmarking these analogs against brassinolide in established plant bioassays, the research refines our understanding of brassinosteroid structure–activity relationships, with practical implications for both plant biology and translational applications.

• Deficiency of H2S and ER Stress in Diabetic Cardiomyopathy

  2026-07-16

  The referenced study uncovers a mechanistic link between reduced endogenous hydrogen sulfide (H2S) production and increased endoplasmic reticulum (ER) stress in diabetic cardiomyopathy, demonstrating that H2S deficiency exacerbates lipotoxic cardiac injury. These findings highlight the therapeutic relevance of restoring H2S signaling in diabetic heart disease models and inform strategies for monitoring H2S dynamics in cellular systems.

• Tioconazole Antifungal Medication: Protocols, Performance, a

  2026-07-15

  Tioconazole sets a high standard in antifungal drug development, combining robust cytochrome P450 inhibition with reliable solubility and purity. This guide translates advanced research findings into actionable workflows and troubleshooting strategies, maximizing Tioconazole's impact in fungal infection models and in vitro assays.

• Tetrandrine Alkaloid: Optimized Protocols for Ion Channel St

  2026-07-15

  Tetrandrine alkaloid empowers researchers in neuroscience and cancer biology with its robust ion channel modulation and high DMSO solubility. This article delivers practical protocol enhancements, troubleshooting strategies, and data-driven insights for maximizing experimental reliability using APExBIO's Tetrandrine.

• SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin

  2026-07-14

  The referenced study demonstrates that SEMA3E promotes beige adipocyte differentiation and thermogenesis in mice through modulation of β-catenin signaling. These findings clarify SEMA3E’s mechanistic role in adipose tissue plasticity and energy regulation, offering new avenues for metabolic disorder research.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Resp

  2026-07-14

  This study introduces a patient-derived gastric cancer assembloid platform that integrates tumor organoids with autologous stromal cell subpopulations, offering a physiologically relevant model for preclinical testing. The approach reveals how stromal heterogeneity modulates drug response, opening new avenues for personalized therapy optimization and resistance mechanism discovery.

• Genetic Engineering and Media Optimization Boost A40926 Yiel

  2026-07-13

  This study demonstrates that combining targeted genetic modifications with systematic media optimization in Nonomuraea gerenzanensis can significantly enhance production of the glycopeptide antibiotic A40926. The findings provide a robust framework for improving yields of complex antibiotics, informing both industrial biosynthesis and laboratory-scale research.

• Dasatinib (BMS-354825): Precision Tools for Kinase Signaling

  2026-07-13

  Dasatinib (BMS-354825) from APExBIO provides unparalleled specificity for dissecting Src and Bcr-Abl kinase pathways in cancer models. This article guides researchers through optimized protocols, advanced applications in EMT and stemness, and troubleshooting strategies grounded in recent mechanistic studies.

• HPF (Hydroxyphenyl Fluorescein): Redefining hROS Detection i

  2026-07-12

  Explore how HPF (hydroxyphenyl fluorescein) enables highly specific detection of reactive oxygen species in advanced cancer and phototherapy models. This article uniquely bridges assay design with mechanistic insights from multimodal phototherapy research.

• Doxorubicin (Adriamycin): Mechanisms, Protocols, and Researc

  2026-07-10

  Doxorubicin, also known as Adriamycin, is a gold-standard chemotherapeutic agent for cancer research, functioning as a potent DNA topoisomerase II inhibitor. Its efficacy is balanced by well-characterized cardiotoxicity risks and precise handling requirements. This article details the molecular rationale, experimental benchmarks, and practical workflow guidance for APExBIO’s Doxorubicin (SKU A3966) in solid tumor and hematologic malignancy research.

• Jasplakinolide: Precision Actin Polymerization Inducer Workf

  2026-07-09

  Jasplakinolide, offered by APExBIO, stands out as a membrane-permeable actin polymerization inducer that enables precise manipulation of the cytoskeleton for advanced cell biology and antifungal research. This article details hands-on experimental workflows, troubleshooting guidance, and key insights from landmark studies—empowering researchers to achieve reproducible, high-impact results.

• Erastin: Precision Ferroptosis Inducer for Advanced Research

  2026-07-09

  Erastin, a gold-standard ferroptosis inducer, uniquely enables highly selective interrogation of iron- and ROS-dependent cell death in RAS/BRAF-mutant tumor models. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies for maximizing reproducibility and mechanistic insight in ferroptosis and cancer biology research.

• ATM-Targeted TACE Silencing for Obesity-Driven Type 2 Diabet

  2026-07-08

  This study introduces a non-viral gene delivery system using ATS-9R to selectively target visceral adipose tissue macrophages (ATMs) and silence TACE, a key mediator of obesity-induced inflammation and insulin resistance. The findings highlight a promising strategy for attenuating metabolic disease at the tissue and cellular level, with implications for future anti-inflammatory therapeutics.

16271 records 1/1085 page Next 12345 下5页 Last page